Back to 
MAI Capital Management
MAI Capital Management
CNSP
4 quarters
Position history for MAI Capital Management's holdings in CNS Pharmaceuticals, Inc.
No. MAI Capital Management exited its CNSP (CNS Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 3 shares worth $8. MAI Capital Management first reported CNSP in Q3 2025 and held it in 3 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$27
Total Shares Change
-3
Quarter-by-Quarter History
Other major holders of CNSP: UBS Group AG, Geode Capital Management, LLC, Vanguard Fiduciary Trust Co., Vanguard Capital Management LLC